Test Price
2,800 AED✅ Home Collection Available
SFTPD Gene Surfactant Metabolism Dysfunction Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل تسلسل جين SFTPD لاضطراب استقلاب الفاعل بالسطح الرئوي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited next‑generation sequencing and bioinformatics pipeline.
- Premium Logistics: ISO‑certified cold‑chain home collection (blood, extracted DNA, or FTA card) available 8 AM–11 PM; VIP mobile phlebotomy service.
- Clinical Guidance: Complimentary post‑test genetic counselling and telephonic clinical result interpretation by a DHA‑licensed genetic specialist.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: يوفر هذا الفحص أعلى درجات الدقة (99.9%) لتشخيص الطفرات الجينية المسببة لخلل استقلاب الفاعل بالسطح الرئوي، مع خدمات منزلية معتمدة من الآيزو، ودعم طبي متكامل بعد النتيجة. الإجراء متوافق تماماً مع توجيهات هيئة الصحة بدبي لعام 2026 وتشريعات الخصوصية الإماراتية.
Overview
The SFTPD NGS test sequences the entire coding region of the surfactant protein D gene to identify pathogenic variants linked to surfactant metabolism dysfunction—a rare, often neonatal-onset interstitial lung disease. This 3‑4 week assay, compliant with 2026 DHA guidelines, delivers a definitive molecular diagnosis that guides targeted respiratory management, family planning, and eligibility for emerging therapies.
يكشف تحليل جين SFTPD المتطور الطفرات المسببة لاعتلال وظائف الفاعل بالسطح الرئوي، مما يتيح تشخيصاً دقيقاً وخطط علاجية مخصصة لحديثي الولادة والأطفال.
| Feature | Our Test (DHA‑Accredited Lab) | Closest Alternative (Overseas Shipment) |
|---|---|---|
| Methodology | NGS (Next-Generation Sequencing) + Sanger confirmation | NGS or exome panel without UAE‑specific variant interpretation |
| Turnaround Time | 3–4 weeks (expedited option available) | 4–8 weeks, plus customs delay |
| Clinical Report | DHA‑standardized, includes ACMG classification & genetic counselling note | Generic report, may lack local regulatory annotations |
| Sample Options | Whole blood, extracted DNA, or dried blood spot on FTA card | Often requires whole blood only |
Physician Insight & Safety Protocol
“As a clinician, I recognise the anxiety that accompanies genetic testing for a child’s respiratory condition. This SFTPD analysis provides clarity, but a normal result does not exclude other surfactant gene defects; clinical correlation with radiology and lung biopsy remains essential. We are here to guide you through every result, ensuring you feel supported and empowered.”
– Dr. PRABHAKAR REDDY (DHA License: 61713011), Senior Medical Geneticist
⚠️ Medication Warning
Do not discontinue prescribed medication (e.g., corticosteroids, bronchodilators, diuretics) without consulting your doctor. This test is for diagnostic purposes only and does not replace ongoing clinical management.
Patient Safety – Exclusion Criteria & Emergency Signs
- Active febrile illness (temp ≥38.5°C) or untreated infection – postpone phlebotomy.
- Severe bleeding diathesis or platelet count <50,000/µL – require medical clearance before blood draw.
- Current use of anticoagulants that cannot be safely held; discuss with the ordering physician.
- Seek immediate emergency care (call 998) if the affected infant exhibits: grunting, chest retractions, cyanosis, or oxygen saturation <90% while on home oxygen.
- In case of sudden deterioration after sample collection, contact your managing pulmonologist or visit the nearest emergency department.
Patient FAQ & Clinical Guidance
1. What is the SFTPD gene test and how does it impact my child’s treatment plan?
Snippet answer: The SFTPD identifies pathogenic mutations that cause surfactant protein D deficiency, enabling neonate-tailored ventilator strategies and possible enrolment in precision medicine trials.
يكشف اختبار SFTPD عن الطفرات المسببة لنقص البروتين الفاعل بالسطح، مما يوجه استراتيجيات التنفس الصناعي المناسبة لحديثي الولادة وقد يؤهل للمشاركة في تجارب العلاج الجيني الدقيق.
2. How long do results take and will a genetic counsellor explain them?
Snippet answer: Report delivery occurs in 21–28 calendar days; a complimentary 20‑minute Arabic/English genetic counselling session is booked immediately upon result notification.
تصدر النتائج خلال 21 إلى 28 يوماً، ويتم حجز جلسة استشارة وراثية مجانية بالعربية أو الإنجليزية فور صدور التقرير.
3. Is home sample collection safe and accepted by UAE insurance?
Snippet answer: Our ISO‑certified phlebotomists follow strict cold‑chain protocols; we verify direct billing eligibility with major insurers via WhatsApp before the visit.
يتبع فريق التمريض المنزلي المعتمد من الآيزو بروتوكولات صارمة لحفظ العينات، ويتم التحقق من تغطية التأمين عبر الواتساب قبل الزيارة.
UAE Healthcare Compliance: Federal Decree-Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors), UAE PDPL (Data Privacy).
ISO 9001:2015 Certified Laboratory (Cert: INT/EGQ/2509DA/3139) | DHA Facility License: 9834453
Support & WhatsApp: +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians